Literature DB >> 34753816

What Is the Best Maintenance Therapy for ANCA Vasculitis?

Katti Woerner1, Patrick H Nachman2.   

Abstract

Entities:  

Keywords:  ANCA; maintenance; vasculitis

Year:  2021        PMID： 34753816      PMCID： PMC8729480          DOI： 10.2215/CJN.09210721

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.

Authors:  Jan-Stephan F Sanders; Anoek A E de Joode; Ruud G DeSevaux; Jan Broekroelofs; Alexandre E Voskuyl; Pieter van Paassen; Cees G M Kallenberg; Jan Willem Cohen Tervaert; Coen A Stegeman
Journal:  Nephrol Dial Transplant       Date:  2016-05-30       Impact factor: 5.992

2.  Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.

Authors:  Emma E van Daalen; Raffaella Rizzo; Andreas Kronbichler; Ron Wolterbeek; Jan A Bruijn; David R Jayne; Ingeborg M Bajema; Chinar Rahmattulla
Journal:  Ann Rheum Dis       Date:  2016-11-29       Impact factor: 19.103

3.  Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.

Authors:  Pierre Charles; Élodie Perrodeau; Maxime Samson; Bernard Bonnotte; Antoine Néel; Christian Agard; Antoine Huart; Alexandre Karras; François Lifermann; Pascal Godmer; Pascal Cohen; Catherine Hanrotel-Saliou; Nicolas Martin-Silva; Grégory Pugnet; François Maurier; Jean Sibilia; Pierre-Louis Carron; Pierre Gobert; Nadine Meaux-Ruault; Thomas Le Gallou; Stéphane Vinzio; Jean-François Viallard; Eric Hachulla; Christine Vinter; Xavier Puéchal; Benjamin Terrier; Philippe Ravaud; Luc Mouthon; Loïc Guillevin
Journal:  Ann Intern Med       Date:  2020-06-02       Impact factor: 25.391

4.  Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Authors:  Loïc Guillevin; Christian Pagnoux; Alexandre Karras; Chahera Khouatra; Olivier Aumaître; Pascal Cohen; François Maurier; Olivier Decaux; Jacques Ninet; Pierre Gobert; Thomas Quémeneur; Claire Blanchard-Delaunay; Pascal Godmer; Xavier Puéchal; Pierre-Louis Carron; Pierre-Yves Hatron; Nicolas Limal; Mohamed Hamidou; Maize Ducret; Eric Daugas; Thomas Papo; Bernard Bonnotte; Alfred Mahr; Philippe Ravaud; Luc Mouthon
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

5.  Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

Authors:  Alexandre Karras; Christian Pagnoux; Marion Haubitz; Kirsten de Groot; Xavier Puechal; Jan Willem Cohen Tervaert; Mårten Segelmark; Loic Guillevin; David Jayne
Journal:  Ann Rheum Dis       Date:  2017-05-25       Impact factor: 19.103

6.  Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Authors:  Christian Pagnoux; Alfred Mahr; Mohamed A Hamidou; Jean-Jacques Boffa; Marc Ruivard; Jean-Pierre Ducroix; Xavier Kyndt; François Lifermann; Thomas Papo; Marc Lambert; José Le Noach; Mehdi Khellaf; Dominique Merrien; Xavier Puéchal; Stéphane Vinzio; Pascal Cohen; Luc Mouthon; Jean-François Cordier; Loïc Guillevin
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

7.  Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

Authors:  Pierre Charles; Benjamin Terrier; Élodie Perrodeau; Pascal Cohen; Stanislas Faguer; Antoine Huart; Mohamed Hamidou; Christian Agard; Bernard Bonnotte; Maxime Samson; Alexandre Karras; Noémie Jourde-Chiche; François Lifermann; Pierre Gobert; Catherine Hanrotel-Saliou; Pascal Godmer; Nicolas Martin-Silva; Grégory Pugnet; Marie Matignon; Olivier Aumaitre; Jean-François Viallard; François Maurier; Nadine Meaux-Ruault; Sophie Rivière; Jean Sibilia; Xavier Puéchal; Philippe Ravaud; Luc Mouthon; Loïc Guillevin
Journal:  Ann Rheum Dis       Date:  2018-04-25       Impact factor: 19.103

8.  Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease.

Authors:  Joanna Tieu; Rona M Smith; Seerapani Gopaluni; Dinakantha S Kumararatne; Mark McClure; Ania Manson; Sally Houghton; David R W Jayne
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

9.  Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.

Authors:  David Jayne; Daniel Blockmans; Raashid Luqmani; Sergey Moiseev; Beulah Ji; Yulia Green; Leanne Hall; David Roth; Robert B Henderson; Peter A Merkel
Journal:  Arthritis Rheumatol       Date:  2019-04-16       Impact factor: 10.995

10.  Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models.

Authors:  Mark E McClure; Yajing Zhu; Rona M Smith; Seerapani Gopaluni; Joanna Tieu; Tasneem Pope; Karl Emil Kristensen; David R W Jayne; Jessica Barrett; Rachel B Jones
Journal:  Rheumatology (Oxford)       Date:  2021-03-02       Impact factor: 7.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.